About Jamieson Laboratories (TSE:JWEL)
Jamieson Wellness Inc. develops, manufactures, distributes, sells, and markets natural health products worldwide. The company operates in two segments, Jamieson Brands and Strategic Partners. The company offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and LVHS brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands. It also provides manufacturing and product development services on a contract manufacturing basis to blue-chip consumer health companies and retailers. Jamieson Wellness Inc. sells its products to distributors, retail, and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is based in Toronto, Canada.
Industry, Sector and Symbol
Industry Packaged Foods
Sub-IndustryN/A
SectorConsumer Defensive
SymbolTSE:JWEL
CUSIPN/A
Phone+1-416-9600052
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4.43%
Return on Equity6.83%
Return on Assets2.90%
Miscellaneous
EmployeesN/A
Outstanding Shares37,740,000
Jamieson Laboratories (TSE:JWEL) Frequently Asked Questions
What is Jamieson Laboratories' stock symbol?
Jamieson Laboratories trades on the Toronto Stock Exchange (TSX) under the ticker symbol "JWEL."
How often does Jamieson Laboratories pay dividends? What is the dividend yield for Jamieson Laboratories?
Jamieson Laboratories announced a quarterly dividend on Tuesday, March 6th. Shareholders of record on Thursday, March 15th will be paid a dividend of 0.08 per share on Thursday, March 15th. This represents a $0.32 annualized dividend and a yield of 1.39%. The ex-dividend date is Tuesday, March 6th. View Jamieson Laboratories' Dividend History.
What price target have analysts set for JWEL?
7 brokers have issued 12 month price objectives for Jamieson Laboratories' stock. Their forecasts range from C$22.00 to C$26.00. On average, they anticipate Jamieson Laboratories' stock price to reach C$23.96 in the next twelve months. View Analyst Ratings for Jamieson Laboratories.
Who are some of Jamieson Laboratories' key competitors?
Some companies that are related to Jamieson Laboratories include Westshore Terminals (WTE), Labrador Iron Ore Royalty (LIF), Pason Systems (PSI), Spin Master (TOY), Chemtrade Logistics (CHE.UN), Mullen Group (MTL), Corus Entertainment (CJR), Corus Entertainment (CJR.B), Freehold Royalties (FRU), CES Energy Solutions (CEU), Aritzia (ATZ), Enerflex (EFX), MEG Energy (MEG), Cascades (CAS), SSR Mining (SSRM), Raging River Exploration (RRX), The North West (NWC) and ECN Capital (ECN).
Who are Jamieson Laboratories' key executives?
Jamieson Laboratories' management team includes the folowing people:
- Mr. Mark Hornick, Pres, CEO & Director
- Mr. Christopher Snowden, CFO & Corp. Sec.
- Ms. Regan Stewart, Chief Operations & People Officer
- Mr. Don Bird, Exec. VP of Global Retail Sales & Marketing (Age 54)
- Mr. Paul Galbraith, VP of Sales
Has Jamieson Laboratories been receiving favorable news coverage?
Media coverage about JWEL stock has trended somewhat positive this week, according to Accern. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Jamieson Laboratories earned a media sentiment score of 0.17 on Accern's scale. They also gave media stories about the company an impact score of 46.37 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Jamieson Laboratories?
Shares of JWEL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Jamieson Laboratories' stock price today?
One share of JWEL stock can currently be purchased for approximately C$23.08.
How big of a company is Jamieson Laboratories?
Jamieson Laboratories has a market capitalization of C$780.68 million.
How can I contact Jamieson Laboratories?
Jamieson Laboratories' mailing address is 2 St. Clair Avenue West, TORONTO, ON M4V 1L5, Canada. The company can be reached via phone at +1-416-9600052.
MarketBeat Community Rating for Jamieson Laboratories (JWEL)
MarketBeat's community ratings are surveys of what our community members think about Jamieson Laboratories and other stocks. Vote "Outperform" if you believe JWEL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JWEL will underperform the S&P 500 over the long term. You may vote once every thirty days.
Jamieson Laboratories (TSE:JWEL) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Jamieson Laboratories in the last 12 months. Their average twelve-month price target is C$23.96, suggesting that the stock has a possible upside of 4.15%. The high price target for JWEL is C$26.00 and the low price target for JWEL is C$22.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | C$23.96 | C$23.96 | C$23.05 | C$20.75 |
| Price Target Upside: | 4.15% upside | 16.22% upside | 2.44% upside | 12.16% upside |
Jamieson Laboratories (TSE:JWEL) Consensus Price Target History
Jamieson Laboratories (TSE:JWEL) Analyst Ratings History
Show:
(Data available from 4/19/2016 forward)
Jamieson Laboratories (TSE:JWEL) Dividend Information
Jamieson Laboratories pays an annual dividend of C$0.16 per share, with a dividend yield of 0.70%. JWEL's most recent quarterly dividend payment was Thursday, March 15.
| Most Recent Dividend: | 3/15/2018 |
| Annual Dividend: | $0.16 |
| Dividend Yield: | 0.70% |
| Payout Ratio: | N/A |
Jamieson Laboratories (TSE:JWEL) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/6/2018 | Quarterly | $0.08 | 1.53% | 3/6/2018 | 3/15/2018 | 3/15/2018 |
| 11/30/2017 | Quarterly | $0.08 | 1.5% | 11/30/2017 | 12/15/2017 | 12/15/2017 |
| 8/30/2017 | | $0.08 | 0.42% | 8/30/2017 | 9/15/2017 | 9/15/2017 |
(Data available from 1/1/2013 forward)
Jamieson Laboratories (TSE JWEL) Insider Trading and Institutional Ownership History
Jamieson Laboratories (TSE JWEL) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/12/2018 | Robert Chan | Insider | Buy | 300 | C$20.66 | C$6,198.00 | | |
| 2/28/2018 | Steven Edward Spooner | Director | Buy | 2,400 | C$20.95 | C$50,280.00 | | |
| 11/24/2017 | David Michael Williams | Director | Buy | 1,500 | C$21.55 | C$32,325.00 | | |
(Data available from 1/1/2013 forward)
Jamieson Laboratories (TSE JWEL) News Headlines
| Source: |
|
Jamieson Laboratories (TSE:JWEL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Jamieson Laboratories (TSE JWEL) Stock Chart for Thursday, April, 19, 2018
Loading chart…
